1 Suda T, TaKahashi T, Golstein P, et al. Molecular cloning and expression of the Fas ligand:a novel member of the tumor necrosis factor family. Cell,1993,75:1169-1178. 2 Norris DA, Travers JB,Leuny DYM. Lymphocyte activation in the pathogenesis of psoriasis.J Invest Dermatol,1997,109:1-4. 3 徐丽敏,陈学荣,殷金珠.角朊细胞凋亡与银屑病.中华皮肤科杂志, 1997,30:235-236. 4 Wrone-Smith T, Mitra RS, Thompson CB, et al. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol,1997,151:1321-1329. 5 Wrone-Smith T,Johnson T, Nelson B, et al. Discordant expression of Bcl-X and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol,1995,146:1079-1088. 6 Berthou C, Michel L, Soulie A, et al. Acquisition of granzyme B and Fas ligand protein by human keratinocytes contributes to epidermal cell defense. J Immunol, 1997,159:5293-5300. 7 Gutierrez-Steil C, Wrone-Smith T, Sun X,et al. Sunlight-induced basal cell carcinoma turmor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest, 1998,101:33-39. 8 Hahne M,Rimoldi D,Schroter M, et al. Melanoma cell expression of Fas (Apo-1/CD95)ligand:Implications for tumor immune escape.Science,1996,274:1363-1366. |